188 related articles for article (PubMed ID: 1690826)
21. [Tumor markers of prostate cancer--evaluation of serum PAP and PA].
Miki M
Gan No Rinsho; 1985 May; 31(6 Suppl):664-9. PubMed ID: 2411965
[TBL] [Abstract][Full Text] [Related]
22. [Primary mucinous adenocarcinoma of the prostate].
Gomiz Léon JJ; Burgos Lázaro F; Ortín García-Nieto M; Herrero Payo JA; Gimeno Albo F; Gómez Tejada L
Actas Urol Esp; 1995 Jun; 19(6):473-5. PubMed ID: 8571808
[TBL] [Abstract][Full Text] [Related]
23. Prostate specific acid phosphatase versus five other possible tumour markers: a comparative study in men with prostatic carcinoma.
Larson A; Fritjofsson A; Norlén BJ; Gronowitz JS; Ronquist G
Scand J Clin Lab Invest Suppl; 1985; 179():81-8. PubMed ID: 2417306
[No Abstract] [Full Text] [Related]
24. Mucin production in prostatic adenocarcinoma: a retrospective study of 190 radical prostatectomy and/ or core biopsy specimens in department of pathology, Siriraj Hospital, Mahidol University, Thailand.
Noiwan S; Rattanarapee S
J Med Assoc Thai; 2011 Feb; 94(2):224-30. PubMed ID: 21534370
[TBL] [Abstract][Full Text] [Related]
25. [Clinical evaluation of prostate antigen (PA) in prostate cancer].
Kuriyama M
Gan No Rinsho; 1985 May; 31(6 Suppl):606-10. PubMed ID: 2411962
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemistry in the diagnosis of difficult cases of prostatic cancer.
Caillaud JM; Mathieu MC; Carlu C
Prog Clin Biol Res; 1987; 243A():477-83. PubMed ID: 2443919
[No Abstract] [Full Text] [Related]
27. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
Sheridan T; Herawi M; Epstein JI; Illei PB
Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
[TBL] [Abstract][Full Text] [Related]
28. Intestinal-type mucinous adenocarcinoma arising from the prostatic duct.
Sakamoto N; Ohtsubo S; Iguchi A; Takeshita M; Kurozumi T
Int J Urol; 2005 May; 12(5):509-12. PubMed ID: 15948756
[TBL] [Abstract][Full Text] [Related]
29. Adenocarcinoma of the prostate: biopsy to whole mount. Denver VA experience.
Donohue RE; Miller GJ
Urol Clin North Am; 1991 Aug; 18(3):449-52. PubMed ID: 1715102
[TBL] [Abstract][Full Text] [Related]
30. [Changes in prostatic acid phosphatase, gamma-seminoprotein and prostate specific antigen after endocrine therapy for stage D2 prostate cancer].
Akimoto S; Akakura K; Masai M; Isaka S; Shimazaki J
Hinyokika Kiyo; 1990 Jul; 36(7):783-91. PubMed ID: 1700588
[TBL] [Abstract][Full Text] [Related]
31. [Clinical significance of tumor markers in prostatic carcinoma--comparative study of prostatic acid phosphatase, prostate specific antigen and gamma-seminoprotein].
Yoshiki T; Okada K; Oishi K; Yoshida O
Hinyokika Kiyo; 1987 Dec; 33(12):2044-9. PubMed ID: 2452559
[TBL] [Abstract][Full Text] [Related]
32. Acid phosphatase, alkaline phosphatase and prostate specific antigen: which markers should we choose?
Cooper EH; Siddall JK; Newling DW; Robinson MR
Prog Clin Biol Res; 1988; 269():43-56. PubMed ID: 2455911
[No Abstract] [Full Text] [Related]
33. Mucinous adenocarcinoma of urinary bladder type arising from the prostatic urethra. Distinction from mucinous adenocarcinoma of the prostate.
Tran KP; Epstein JI
Am J Surg Pathol; 1996 Nov; 20(11):1346-50. PubMed ID: 8898838
[TBL] [Abstract][Full Text] [Related]
34. [Prostatic carcinoma: immunoperoxidase study with antisera against prostatic acid phosphatase and the prostate-specific antigen].
Mathieu MC; Caillaud JM
Bull Cancer; 1985; 72(5):405-13. PubMed ID: 2416371
[TBL] [Abstract][Full Text] [Related]
35. Clear cell adenocarcinoma of the female urethra showing positive staining with antibodies to prostate-specific antigen and prostatic acid phosphatase.
Ebisuno S; Miyai M; Nagareda T
Urology; 1995 Apr; 45(4):682-5. PubMed ID: 7536368
[TBL] [Abstract][Full Text] [Related]
36. [Prostate-specific antigen. A new biological serum marker for prostatic adenocarcinoma].
Haukaas S; Skaarland E; Halvorsen OJ; Stensland E; Farstad M
Tidsskr Nor Laegeforen; 1990 Sep; 110(23):2990-3. PubMed ID: 1700496
[TBL] [Abstract][Full Text] [Related]
37. Screening for adenocarcinoma of the prostate.
Miles BJ
Henry Ford Hosp Med J; 1989; 37(1):5-7. PubMed ID: 2475458
[No Abstract] [Full Text] [Related]
38. [Clinical evaluation of a prostate-specific antigen as a serum marker of prostatic cancer].
Park YC; Kiwamoto H; Nishioka T; Tsujihashi H; Mitsubayashi S; Matsuura T; Akiyama T; Kurita T; Miyamoto T
Hinyokika Kiyo; 1987 Jun; 33(6):883-8. PubMed ID: 2445188
[TBL] [Abstract][Full Text] [Related]
39. Monitoring of prostate-specific antigen during external beam radiotherapy for carcinoma of the prostate.
van Eijkeren M; van Haelst JP
Strahlenther Onkol; 1990 Aug; 166(8):557-61. PubMed ID: 1697702
[TBL] [Abstract][Full Text] [Related]
40. [Mucinous adenocarcinoma of the prostate. A case report and analysis of the literature].
Watarai Y; Demura T; Togashi M; Ohashi N; Chikaraishi T; Hirano T; Fukazawa Y
Nihon Hinyokika Gakkai Zasshi; 1994 Aug; 85(8):1276-9. PubMed ID: 7523749
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
